[1] 国家中医药管理局《中华本草》编委会. 中华本草[M]. 上海: 上海科技出版社, 1999: 1390. [2] 全国中草药汇编编写组.全国中草药汇编[M]. 北京:人民卫生出版社,1975,112-113. [3] 刘文泰.本草品汇精要[M].北京:人民卫生出版社, 1982:245. [4] 何克谏. 生草药性备要[M]. 广东科技出版社.2009. [5] 梁爱华,叶祖光. 千里光属植物的毒性研究进展[J].中国中药杂志,2006,31(2):93-97. [6] Chinese herbal medicine editorial committee belonging to the State Administration of Traditional Chinese Medicine.Chinese Herbal Medicine: Vol 21 (7)(中华本草: 第21卷)[M]. Shanghai: Shanghai Science and Technology Publishers,1999: 942-947. [7] Institute of Materia Medica Chinese Academy of MedicalSciences. Chinese Medicine Notes: Vol 4 (中药志: 第4卷)[M]. Beijing: People's Medical Publishing House, 1969:166-170. [8] 国家药典委员会.中华人民共和国药典(一部)[S].北京:中国医药科技出版社,2010:32. [9] 程卫强,隋长惠,胡伟利,等. 羽叶千里光的显微鉴定[J]. 沈阳药科大学学报,2000,17(1): 63-65. [10] 熊爱珍,杨莉,杨雪晶,等. UPLC-MS 同时测定千里光和欧洲千里光中阿多尼佛林碱和千里光碱的含量[J].中国中药杂志.2011,36(6):702-705. [11] 杨雪晶,杨莉,徐红,等. 千里光属 (Senecio) 13 种植物的形态和组织学特征[J].药学学报. 2011,46 (7): 864-876. [12]赵显国,王峥涛,张勉,等.肝毒毗咯里西淀生物碱与中草药[J].中草药,1998,29(5):343-345. [13] 程刚,夏东胜,李馨龄,等.千里光的安全性研究现状及其对策探讨[J].中国中医药信息杂志,2004,11(7):569-606. [14] Culvenor C C.Estimated intakes of pyrrolizidine alkaloids by humans[J].Journal of Toxicology and Environmental Health,1983, 11(4-6):625-635. [15] Dharmananda S. Safety issues affecting herbs: pyrrolizidine alkaloid[EB/OL].[2014-09-01](2001-11). http://www.itmonline.org/arts/pas.htm. [16] Lin G, Li S L, Li M, et al. Qianliguang (Senecio scandens) safety dilemma:dose is the key[J].Planta Med, 2009, 75(10): 1107-1111. [17] Stickel F,Schuppan D.Herbal medicine in the treatment of liver diseases[J].Dig Liver diseases ,2007,39(4):293. [18] 胡军.千里光属植物化学成分的研究进展[J].中成药.2007,29(4):567-570. [19] 梁爱华,叶祖光.正视千里光属中草药毒性研究[N].中国医药报, 2006-8-22 (A07). [20] 刘明宣,王川东.肌注千里光过敏致死一例[J].四川医学,1983,4(4):246. [21] 郭兆广,曾宪.千柏鼻炎片临床疗效分析[J].广州医药, 1987,18(2): 50. [22] Khakpour N, Hunt K K, Kuerer H M, et al. Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node[J]. The American journal of surgery, 2005, 190(4): 598-601. [23] Smith L W, Culvenor C C J. Plant sources of hepatotoxic pyrroli-zidine alkaloids[J]. Journal of Natural Products, 1981, 44(2): 129-152. [24] WHO. Environmental Health Criteria 80, pyrrolizidine alkaloids[EB/OL].(1988)[2004-09-01]. http://apps.who.int/iris/bitstream/10665/39027/1/WHO_EHC_80_eng.pdf?ua=1. [25] Altaee M Y, Mahmood M H. An outbreak of veno-occlusive disease of the liver in northern Iraq[J]. Eastern Mediterranean Health Journal, 1998, 4(1): 142-148. [26] 张永东. 千柏鼻炎片引起肝脏损害1例[J].郴州医学院学报.2003, 5 (1):6. [27] Roulet M, Laurini R, Rivier L, et al. Hepatic veno-occlusive disease in newborn infant of a woman drinking herbal tea[J]. The Journal of pediatrics, 1988, 112(3): 433-436. [28] Vilar J H, Garcia M, Cabrera P. Veno-occlusive liver disease induced by Senecio vulgaris toxicity[J]. Gastroenterologia y hepatologia, 1999, 23(6): 285-286. [29] Wilmot F C,Robertson G W.Senecio disease or cirrhosis of the liver due to Senecio poisoning [J]. The Lancet,1920,23(10):848-849. [30] Tomioka M, Calvo F, Siguas A, et al. Hepatic veno-occlusive disease associated with ingestion of Senecio tephrosioides[J]. Revista de gastroenterologia del Peru: organo oficial dela Sociedad de Gastroenterologia del Peru, 1994, 15(3): 299-302. [31] Magnabosco E M, Rivera M L, Prolla I R, et al. Hepatic veno-occlusive disease: report of a case[J]. Jornal de pediatria, 1996, 73(2): 115-118. [32] 孟凡君,张雪君,谢卫东.中草药千里光研究进展[J]. 东北农业大学学报.2010,41(9):156-160. |